EUROFINS SCIENT Income from Continuous Operations 2018-2025 | ERFSF
EUROFINS SCIENT annual/quarterly income from continuous operations history and growth rate from 2018 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- EUROFINS SCIENT income from continuous operations for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT income from continuous operations for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT annual income from continuous operations for 2024 was $0.439B, a 31.72% increase from 2023.
- EUROFINS SCIENT annual income from continuous operations for 2023 was $0.333B, a 47.81% decline from 2022.
- EUROFINS SCIENT annual income from continuous operations for 2022 was $0.638B, a 31.1% decline from 2021.
| EUROFINS SCIENT Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $439 |
| 2023 | $333 |
| 2022 | $638 |
| 2021 | $926 |
| 2020 | $617 |
| 2019 | $219 |
| 2018 | $264 |
| 2017 | $247 |
| 2016 | $241 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.467B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.528B | 27.92 |
| CVS Health (CVS) | United States | $84.635B | 10.52 |
| Elevance Health (ELV) | United States | $66.524B | 8.95 |
| Cencora (COR) | United States | $57.169B | 19.04 |
| DiDi Global (DIDIY) | China | $25.839B | 27.45 |
| Labcorp Holdings (LH) | United States | $22.541B | 17.92 |
| Natera (NTRA) | United States | $21.746B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| ICON (ICLR) | Ireland | $14.162B | 13.62 |
| CochLear (CHEOY) | Australia | $12.971B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.885B | 34.10 |
| Solventum (SOLV) | United States | $12.692B | 13.10 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.402B | 0.00 |
| Revvity (RVTY) | United States | $10.383B | 18.29 |
| Sonic Healthcare (SKHHY) | Australia | $9.173B | 0.00 |
| Avantor (AVTR) | United States | $8.849B | 12.98 |
| Charles River Laboratories (CRL) | United States | $7.668B | 14.55 |
| HealthEquity (HQY) | United States | $7.561B | 33.12 |
| Bausch + Lomb (BLCO) | Canada | $4.984B | 33.52 |
| Sotera Health (SHC) | United States | $4.477B | 25.02 |
| BrightSpring Health Services (BTSG) | United States | $4.000B | 30.51 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.530B | 80.84 |
| Concentras Parent (CON) | United States | $2.998B | 19.02 |
| Alignment Healthcare (ALHC) | United States | $2.935B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.885B | 36.29 |
| Organon (OGN) | United States | $2.441B | 2.66 |
| Premier (PINC) | United States | $2.028B | 15.39 |
| Progyny (PGNY) | United States | $1.939B | 41.00 |
| Ardent Health (ARDT) | United States | $1.787B | 6.90 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.353B | 9.03 |
| Teladoc Health (TDOC) | United States | $1.290B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.230B | 20.82 |
| Omada Health (OMDA) | $1.175B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.811B | 4.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.716B | 8.85 |
| CareDx (CDNA) | United States | $0.629B | 11.59 |
| Nutex Health (NUTX) | United States | $0.617B | 9.35 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| So-Young (SY) | China | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.481B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.477B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.468B | 10.53 |
| Agilon Health (AGL) | United States | $0.439B | 0.00 |
| SBC Medicals (SBC) | United States | $0.421B | 9.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.407B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 24.63 |
| Oncology Institute (TOI) | United States | $0.327B | 0.00 |
| LifeMD (LFMD) | United States | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.273B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| KindlyMD (NAKA) | United States | $0.114B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |